Whitehawk Therapeutics, Inc. — SC 13D/A Filings
19 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Whitehawk Therapeutics, Inc. (WHWK), sorted by most recent first. Each row links to the full filing on EdgarLookup. Whitehawk Therapeutics, Inc. has filed 19 SC 13D/A documents with the SEC since 2008. To view all SEC filings by Whitehawk Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10QSB
10SB12G
144
3
4
4/A
424B3
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DEFM14C
EFFECT
POS AM
PRE 14A
PREM14A
PREM14C
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | SC 13D/A | 0001193125-24-230376 | Oct 1, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-009518 | Jan 17, 2023 | — |
| SC 13D/A | AADI BIOSCIENCE, INC. | 0000902664-22-004355 | Sep 26, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-21-328045 | Nov 12, 2021 | — |
| SC 13D/A | AMENDMENT NO. 3 | 0000947871-21-000981 | Sep 3, 2021 | — |
| SC 13D/A | AADI BIOSCIENCE, INC. | 0000902664-21-004068 | Aug 30, 2021 | — |
| SC 13D/A | SC 13D/A | 0001193125-20-299536 | Nov 23, 2020 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000947871-20-000865 | Nov 12, 2020 | — |
| SC 13D/A | SC 13D/A | 0001104659-20-061960 | May 15, 2020 | — |
| SC 13D/A | SC 13D/A | 0001104659-20-049516 | Apr 22, 2020 | — |
| SC 13D/A | SC 13D/A | 0001104659-19-034544 | Jun 7, 2019 | — |
| SC 13D/A | SC 13D/A | 0001104659-19-024279 | Apr 29, 2019 | — |
| SC 13D/A | SC 13D | 0001104659-19-020778 | Apr 11, 2019 | — |
| SC 13D/A | SC 13D/A | 0001104659-19-018338 | Mar 28, 2019 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-007481 | Jan 11, 2019 | — |
| SC 13D/A | SC 13D/A | 0001193125-18-292337 | Oct 4, 2018 | — |
| SC 13D/A | SC 13DA | 0001140361-18-031924 | Jul 9, 2018 | — |
| SC 13D/A | SC 13D/A | 0001193125-18-212530 | Jul 3, 2018 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-18-000540 | Jul 2, 2018 | — |